Please note: The information displayed on this page might be outdated.
HemoShear Therapeutics: HemoShear Therapeutics discovers novel biological targets and advances drug programs to treat metabolic disorders with significant unmet patient need. The Company's lead programs in propionic and methylmalonic acidemia (rare inborn errors of metabolism) will enter phase 2 studies this year.
Sector/Industry:
Biotech Company
Characteristics:
Based in...
US - South Atlantic
Disease Space
Metabolic Disorders
Listing
Private
Website:
Profiles:
Address:
501 Locust Avenue - Suite 301
Charlottesville, VA 22902
United States

Company Participants at Summer 2020 NYC Private Company Showcase

  • James Powers, Chairman and CEO